Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Aug 28, 2026

GRI — GRI Bio, Inc. Dilution Risk Tracker

Track GRI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GRI — Get alerts when the score changes →

As of August 28, 2026, GRI Bio, Inc. (GRI) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. GRI Bio, Inc. has a market capitalization of $3.65M, 2.19M shares outstanding, 6 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
15
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration model 10%
• Score in HIGH risk zone (61/100)
🔔 Track GRI — Get forecast alerts →

Market Data

Market Cap$3.65M
Shares Outstanding2.19M
Float1.77M
Cash$10.95M
Debt$58.0K
Short InterestN/A

Institutional Holdings

6 institutional holders · 28.2K shares
#1 Geode Capital Management, LLC 18.4K shares
#2 UBS Group AG 8.7K shares
#3 Tower Research Capital LLC (TRC) 1.1K shares
+ 3 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest110.0K
Days to Cover4.5
% of Float6.2%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2023-12-31
Full SEC filing analysis available with free account

Recent News

Factual GRI Dilution Snapshot

GRI Bio, Inc. (GRI) has a DilutionScore of 61/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track GRI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GRI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GRI
GRI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.